BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1399144)

  • 1. Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity.
    Blottière HM; Burg C; Zennadi R; Perrin P; Blanchardie P; Bara J; Meflah K; Le Pendu J
    Int J Cancer; 1992 Oct; 52(4):609-18. PubMed ID: 1399144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines.
    Blottière HM; Zennadi R; Burg C; Douillard JY; Meflah K; Le Pendu J
    Int J Cancer; 1992 Feb; 50(4):659-64. PubMed ID: 1537634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of rat colon carcinoma cells to lymphokine activated killer-mediated cytotoxicity is decreased by alpha1,2-fucosylation.
    Marionneau S; Bureau V; Goupille C; Hallouin F; Rocher J; Vaydie B; Le Pendu J
    Int J Cancer; 2000 Jun; 86(5):713-7. PubMed ID: 10797295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
    Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
    Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cells.
    Pelletier H; Olsson NO; Fady C; Reisser D; Lagadec P; Jeannin JF
    Cancer Immunol Immunother; 1988; 26(3):263-8. PubMed ID: 3383206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells.
    Lobo PI; Patel HC
    Immunology; 1994 Oct; 83(2):240-4. PubMed ID: 7835941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.
    Blottière HM; Zennadi R; Grégoire M; Aillet G; Denis MG; Meflah K; Le Pendu J
    Int J Cancer; 1993 Feb; 53(3):409-17. PubMed ID: 8428794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
    Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
    J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro natural killer activity against progressive and regressive variants of a rat colon adenocarcinoma. Effect of treatments with anti-asialo GM1 plus complement.
    Pelletier H; Olsson NO; Shimizu T; Lagadec P; Fady C; Reisser D; Jeannin JF
    Immunobiology; 1987 Sep; 175(3):202-13. PubMed ID: 3679281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis.
    Lobo PI; Chang MY; Mellins E
    Immunology; 1996 Aug; 88(4):625-9. PubMed ID: 8881767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thomsen-Friedenreich (T) antigen expression increases sensitivity of natural killer cell lysis of cancer cells.
    Sotiriadis J; Shin SC; Yim D; Sieber D; Kim YB
    Int J Cancer; 2004 Sep; 111(3):388-97. PubMed ID: 15221966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
    Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
    Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.
    Lee YH; Liao YJ; Huang CH; Chang FL; Fan TH; Twu YC
    Transfusion; 2017 Apr; 57(4):1040-1051. PubMed ID: 28337749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.